表紙:ライム病診断の世界市場:産業分析、動向、市場規模、2027年までの予測
市場調査レポート
商品コード
1068614

ライム病診断の世界市場:産業分析、動向、市場規模、2027年までの予測

Lyme Disease Diagnostics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027

出版日: | 発行: Infinium Global Research (IGR) | ページ情報: 英文 100 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=135.61円
ライム病診断の世界市場:産業分析、動向、市場規模、2027年までの予測
出版日: 2022年03月01日
発行: Infinium Global Research (IGR)
ページ情報: 英文 100 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界のライム病診断の市場規模は、予測期間中に健全なCAGRで成長すると予想されています。

当レポートでは世界のライム病診断市場について調査分析し、市場の概要と予測、市場の促進要因・抑制要因の分析、セグメント別・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 序文

  • レポートの説明
  • 調査方法
  • 調査アプローチ

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 市場の予測
  • 市場の地域的ハイライト

第3章 世界のライム病診断市場:概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • COVID-19の影響分析
  • ポーターのファイブフォース分析
  • IGR-成長マトリックス分析
    • 新たな診断技術別
    • エンドユーザー別
    • 地域別
  • バリューチェーン分析

第4章 ライム病診断市場:マクロ指標分析

第5章 世界のライム病診断市場:新たな診断技術別

  • 血清学的検査
  • 尿中抗原検査
  • 免疫蛍光染色
  • 核酸検査
  • その他

第6章 世界のライム病診断市場:エンドユーザー別

  • 病院
  • 公営および民間研究所

第7章 世界のライム病診断市場(2021年~2027年):地域別

  • 北米
    • 新たな診断技術別
    • エンドユーザー別
    • 国別
  • 欧州
    • 新たな診断技術別
    • エンドユーザー別
    • 国別
  • アジア太平洋
    • 新たな診断技術別
    • エンドユーザー別
    • 国別
  • その他の地域
    • 新たな診断技術別
    • エンドユーザー別
    • サブリージョン別

第8章 企業プロファイルと競合情勢

  • 競合情勢
  • 企業プロファイル
    • Abbott Laboratories
    • T2 Biosystems
    • Bio-Rad Laboratories
    • Alere Inc.
    • Roche Diagnostics International Ltd.
    • Graphene Frontiers
    • Covance Inc.
目次
Product Code: HC08769

The report on the global lyme disease diagnostics market provides qualitative and quantitative analysis for the period from 2019 to 2027. The report predicts the global lyme disease diagnostics market to grow with a healthy CAGR over the forecast period from 2021-2027. The study on lyme disease diagnostics market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2019 to 2027.

The report on lyme disease diagnostics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global lyme disease diagnostics market over the period of 2019 to 2027. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global lyme disease diagnostics market over the period of 2019 to 2027. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • Rising prevalence of lyme disease
  • Increasing focus of governments towards improvement of healthcare facilities

2) Restraints

  • Inefficiency in lyme disease testing

3) Opportunities

  • Players of the lyme disease diagnosis market are focusing on research and development

Research Methodology

A) Primary Research

Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include

  • 1. Key Opinion Leaders associated with Infinium Global Research
  • 2. Internal and External subject matter experts
  • 3. Professionals and participants from the industry

Our primary research respondents typically include

  • 1. Executives working with leading companies in the market under review
  • 2. Product/brand/marketing managers
  • 3. CXO level executives
  • 4. Regional/zonal/ country managers
  • 5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

  • 1. Company reports and publications
  • 2. Government/institutional publications
  • 3. Trade and associations journals
  • 4. Databases such as WTO, OECD, World Bank, and among others.
  • 5. Websites and publications by research agencies

Segment Covered

The global lyme disease diagnostics market is segmented on the basis of emerging diagnostic technology, and end user.

The Global Lyme Disease Diagnostics Market by Emerging Diagnostic Technology

  • Serological Test
  • Urine Antigen Tests
  • Immunofluorescent Staining
  • Nucleic Acid Test
  • Others

The Global Lyme Disease Diagnostics Market by End User

  • Hospitals
  • Public and Private Laboratories

Company Profiles

The companies covered in the report include

  • Abbott Laboratories
  • T2 Biosystems
  • Bio-Rad Laboratories
  • Alere Inc.
  • Roche Diagnostics International Ltd.
  • Graphene Frontiers
  • Covance Inc.

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the lyme disease diagnostics market.

2. Complete coverage of all the segments in the lyme disease diagnostics market to analyze the trends, developments in the global market and forecast of market size up to 2027.

3. Comprehensive analysis of the companies operating in the global lyme disease diagnostics market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Table of Contents

1. Preface

  • 1.1. Report Description
  • 1.2. Research Methods
  • 1.3. Research Approaches

2. Executive Summary

  • 2.1. Lyme Disease Diagnostics Market Highlights
  • 2.2. Lyme Disease Diagnostics Market Projection
  • 2.3. Lyme Disease Diagnostics Market Regional Highlights

3. Global Lyme Disease Diagnostics Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
    • 3.2.2. Restraints
    • 3.2.3. Opportunities
  • 3.3. Analysis of COVID-19 impact on the Lyme Disease Diagnostics Market
  • 3.4. Porter's Five Forces Analysis
  • 3.5. IGR-Growth Matrix Analysis
    • 3.5.1. IGR-Growth Matrix Analysis by Emerging Diagnostic Technology
    • 3.5.2. IGR-Growth Matrix Analysis by End User
    • 3.5.3. IGR-Growth Matrix Analysis by Region
  • 3.6. Value Chain Analysis of Lyme Disease Diagnostics Market

4. Lyme Disease Diagnostics Market Macro Indicator Analysis

5. Global Lyme Disease Diagnostics Market by Emerging Diagnostic Technology

  • 5.1. Serological Test
  • 5.2. Urine Antigen Tests
  • 5.3. Immunofluorescent Staining
  • 5.4. Nucleic Acid Test
  • 5.5. Others

6. Global Lyme Disease Diagnostics Market by End User

  • 6.1. Hospitals
  • 6.2. Public and Private Laboratories

7. Global Lyme Disease Diagnostics Market by Region 2021-2027

  • 7.1. North America
    • 7.1.1. North America Lyme Disease Diagnostics Market by Emerging Diagnostic Technology
    • 7.1.2. North America Lyme Disease Diagnostics Market by End User
    • 7.1.3. North America Lyme Disease Diagnostics Market by Country
  • 7.2. Europe
    • 7.2.1. Europe Lyme Disease Diagnostics Market by Emerging Diagnostic Technology
    • 7.2.2. Europe Lyme Disease Diagnostics Market by End User
    • 7.2.3. Europe Lyme Disease Diagnostics Market by Country
  • 7.3. Asia-Pacific
    • 7.3.1. Asia-Pacific Lyme Disease Diagnostics Market by Emerging Diagnostic Technology
    • 7.3.2. Asia-Pacific Lyme Disease Diagnostics Market by End User
    • 7.3.3. Asia-Pacific Lyme Disease Diagnostics Market by Country
  • 7.4. RoW
    • 7.4.1. RoW Lyme Disease Diagnostics Market by Emerging Diagnostic Technology
    • 7.4.2. RoW Lyme Disease Diagnostics Market by End User
    • 7.4.3. RoW Lyme Disease Diagnostics Market by Sub-region

8. Company Profiles and Competitive Landscape

  • 8.1. Competitive Landscape in the Global Lyme Disease Diagnostics Market
  • 8.2. Companies Profiles
    • 8.2.1. Abbott Laboratories
    • 8.2.2. T2 Biosystems
    • 8.2.3. Bio-Rad Laboratories
    • 8.2.4. Alere Inc.
    • 8.2.5. Roche Diagnostics International Ltd.
    • 8.2.6. Graphene Frontiers
    • 8.2.7. Covance Inc.